Exact Mass: 419.1481

Exact Mass Matches: 419.1481

Found 77 metabolites which its exact mass value is equals to given mass value 419.1481, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

SCD1 Inhibitor

N-{4-[(2-methoxyethyl)(methyl)amino]phenyl}-2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carboxamide

C21H20F3N3O3 (419.1457)

Glycine, L-gamma-glutamyl-2-(1-methyl-4-(nitrosothio)-4-piperidinyl)glycyl-

2-Amino-4-({[(carboxymethyl)-C-hydroxycarbonimidoyl][1-methyl-4-(nitrososulphanyl)piperidin-4-yl]methyl}-C-hydroxycarbonimidoyl)butanoic acid

C15H25N5O7S (419.1475)

Perphenazine sulfoxide

2-chloro-10-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl}-10H-5lambda4-phenothiazin-5-one

C21H26ClN3O2S (419.1434)

5-(alpha-Glucosidomethyl)deoxycytidin|O5-D-glucopyranosyloxymethyl-2-deoxy-cytidine

C16H25N3O10 (419.154)

Cys Asn Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C15H25N5O7S (419.1475)

Cys Asn Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7S (419.1475)

Cys Pro Asn Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C15H25N5O7S (419.1475)

Cys Pro Ser Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C15H25N5O7S (419.1475)

Cys Ser Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7S (419.1475)

Cys Ser Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C15H25N5O7S (419.1475)

Perphenazine sulfoxide

C21H26ClN3O2S (419.1434)

7-Hydroxyperphenazine

C21H26ClN3O2S (419.1434)

8-Hydroxy-perphenazine

C21H26ClN3O2S (419.1434)

Perphenazine-N-oxide

C21H26ClN3O2S (419.1434)

Asn Cys Pro Ser

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C15H25N5O7S (419.1475)

Asn Cys Ser Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7S (419.1475)

Asn Pro Cys Ser

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H25N5O7S (419.1475)

Asn Pro Ser Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H25N5O7S (419.1475)

Asn Ser Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7S (419.1475)

Asn Ser Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C15H25N5O7S (419.1475)

Pro Cys Asn Ser

(2S)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-3-hydroxypropanoic acid

C15H25N5O7S (419.1475)

Pro Cys Ser Asn

(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]propanoic acid

C15H25N5O7S (419.1475)

Pro Asn Cys Ser

(2S)-2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H25N5O7S (419.1475)

Pro Asn Ser Cys

(2R)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C15H25N5O7S (419.1475)

Pro Ser Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]propanoic acid

C15H25N5O7S (419.1475)

Pro Ser Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-sulfanylpropanoic acid

C15H25N5O7S (419.1475)

Ser Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7S (419.1475)

Ser Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C15H25N5O7S (419.1475)

Ser Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C15H25N5O7S (419.1475)

Ser Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C15H25N5O7S (419.1475)

Ser Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C15H25N5O7S (419.1475)

Ser Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C15H25N5O7S (419.1475)

METHYL 2-[(3-ETHOXYCARBONYL-PROPYL)-(TOLUENE-4-SULFONYL)-AMINO]-BENZOATE

C21H25NO6S (419.1403)

(3R,4S)-3-Azetidinepropanoic acid,1-(4-fluorophenyl)-2-oxo-4[4(phenylmethoxy)phenyl]-methyl ester

C25H22FNO4 (419.1533)

Fmoc-(S)-3-Amino-4-(2-fluoro-phenyl)-butyric acid

C25H22FNO4 (419.1533)

(S)-N-FMOC-alpha-Methyl-2-fluorophenylalanine

C25H22FNO4 (419.1533)

Fmoc-(S)-3-Amino-4-(4-fluorophenyl)-butyric acid

C25H22FNO4 (419.1533)

Fmoc-(R)-3-Amino-4-(2-fluorophenyl)-butyric acid

C25H22FNO4 (419.1533)

(R)-FMOC-4-FLUORO-BETA-HOMOPHE-OH

C25H22FNO4 (419.1533)

Fmoc-(S)-3-Amino-4-(3-fluorophenyl)-butyric acid

C25H22FNO4 (419.1533)

Norfloxacin Succinil

C20H22FN3O6 (419.1493)

z-phe-pna

C23H21N3O5 (419.1481)

N-(2-(3-(PIPERAZIN-1-YLMETHYL)IMIDAZO[2,1-B]THIAZOL-6-YL)PHENYL)PYRAZINE-2-CARBOXAMIDE

C21H21N7OS (419.1528)

Nampt-IN-1

C20H25N3O5S (419.1515)

SCD1 inhibitor

N-(4-((2-Methoxyethyl)(methyl)amino)phenyl)-2-phenyl-5-(trifluoromethyl)oxazole-4-carboxamide

C21H20F3N3O3 (419.1457)

fmoc-(r)-3-amino-4-(3-fluoro-phenyl)-butyric acid

C25H22FNO4 (419.1533)

CHIR-124

4-[(3s)-1-Azabicyclo[2.2.2]oct-3-Ylamino]-3-(1h-Benzimidazol-2-Yl)-6-Chloroquinolin-2(1h)-One

C23H22ClN5O (419.1513)

(3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydrobenzo[g]indazole-7-carboxylic acid

C24H22ClN3O2 (419.14)

4-[(4-Fluorophenyl)-(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)methyl]-1-piperazinecarboxylic acid ethyl ester

C19H22FN5O3S (419.1427)

4-(5-Benzenesulfonylamino-1-methyl-1H-benzoimidazol-2-ylmethyl)-benzamidine

C22H21N5O2S (419.1416)

(1S,2R,5S)-5-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-A]pyrazin-7(8H)-YL]-2-(2,4,5-trifluorophenyl)cyclohexanamine

C18H19F6N5 (419.1545)

7-[(2-Chloro-6-fluorophenyl)methyl]-1,3-dimethyl-8-(1-piperidinylmethyl)purine-2,6-dione

C20H23ClFN5O2 (419.1524)

N-{4-[(1h-Benzotriazol-1-Ylacetyl)(Thiophen-3-Ylmethyl)amino]phenyl}propanamide

C22H21N5O2S (419.1416)

2-ethyl 4-isopropyl 5-{[3-(1,5-dimethyl-1H-pyrazol-4-yl)acryloyl]amino}-3-methyl-2,4-thiophenedicarboxylate

C20H25N3O5S (419.1515)

4-[[(4-acetamidophenyl)sulfonylamino]methyl]-N-(3-methoxypropyl)benzamide

C20H25N3O5S (419.1515)

N-[2-[(1,3-benzodioxol-5-ylmethylamino)-oxomethyl]phenyl]-2-ethoxy-3-pyridinecarboxamide

C23H21N3O5 (419.1481)

N-[(2S,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide

C20H25N3O5S (419.1515)

N-[(2S,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide

C20H25N3O5S (419.1515)

N-[(2S,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide

C20H25N3O5S (419.1515)

N-[(2R,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide

C20H25N3O5S (419.1515)

N-[(2R,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide

C20H25N3O5S (419.1515)

N-[(2R,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide

C20H25N3O5S (419.1515)

N-[(2S,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide

C20H25N3O5S (419.1515)

N-[(2R,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide

C20H25N3O5S (419.1515)

N(6)-acetyl-N(2)-(5-phosphopyridoxyl)-L-lysine

C16H26N3O8P (419.1457)

A N(6)-acyl-L-lysine arising from reductive N-alkylation of N(6)-acetyl-L-lysine by pyridoxal-5-phosphate.

ST 19:5;O6;Gly

C21H25NO8 (419.158)

hnRNPK-IN-1

C23H21N3O5 (419.1481)

hnRNPK-IN-1 is a heterogeneous nuclear ribonucleoprotein K (hnRNPK) binding ligand with Kd values of 4.6 μM and 2.6 μM measured with SPR and MST, respectively. hnRNPK-IN-1 inhibits c-myc transcription by disrupting the binding of hnRNPK and c-myc promoter. hnRNPK-IN-1 induces Hela cells apoptosis and has strongly anti-tumor activities[1].

3-{[4-(hex-4-enoyl)-5,7-dihydroxy-3,6,7a-trimethyl-2-oxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

C21H25NO8 (419.158)

3-{[7-hydroxy-4-(1-hydroxyhex-4-en-1-ylidene)-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

C21H25NO8 (419.158)

10,17,19-trihydroxy-13-(methoxymethyl)-8,12-dimethyl-14-oxa-18-azapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),18-diene-2,7,15-trione

C21H25NO8 (419.158)

(2e)-3-{[(3s,3ar,7as)-4-[(4e)-hex-4-enoyl]-5,7-dihydroxy-3,6,7a-trimethyl-2-oxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

C21H25NO8 (419.158)

(1r,4r,8s,10r,12r,13s,16s,17s)-10,17,19-trihydroxy-13-(methoxymethyl)-8,12-dimethyl-14-oxa-18-azapentacyclo[10.7.0.0¹,¹⁶.0³,¹¹.0⁴,⁸]nonadeca-3(11),18-diene-2,7,15-trione

C21H25NO8 (419.158)

(2e)-3-{[(3s,3ar,4z,7as)-7-hydroxy-4-[(4e)-1-hydroxyhex-4-en-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

C21H25NO8 (419.158)